Influence of verapamil on the coronary arteriovenous difference in long chain free fatty acids in hypertrophic cardiomyopathy
- PMID: 1618255
- DOI: 10.1007/BF00278488
Influence of verapamil on the coronary arteriovenous difference in long chain free fatty acids in hypertrophic cardiomyopathy
Abstract
The percentage composition of free fatty acids in the coronary circulation has been studied during the passage of blood through the heart in patients with hypertrophic cardiomyopathy. Under basal conditions the percentages of palmitic and stearic acid decreased significantly. Verapamil i.v. produced a tendency towards a preferential myocardial uptake of oleic acid.
Similar articles
-
[Myocardial metabolism of non-esterified fatty acids].Pathol Biol (Paris). 1969 Jun-Jul;17(11):559-64. Pathol Biol (Paris). 1969. PMID: 4906277 French. No abstract available.
-
[Myocardial retention of free fatty acids in man: study of individual fatty acids and action of various pharmacodynamic agents].Clin Chim Acta. 1969 Mar;23(3):387-96. doi: 10.1016/0009-8981(69)90338-6. Clin Chim Acta. 1969. PMID: 5794476 French. No abstract available.
-
Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans.J Clin Invest. 1987 Feb;79(2):359-66. doi: 10.1172/JCI112820. J Clin Invest. 1987. PMID: 3805273 Free PMC article.
-
Membrane incorporation of non-esterified fatty acids and effects on the sodium pump of human erythrocytes.Clin Sci (Lond). 1992 Jan;82(1):99-104. doi: 10.1042/cs0820099. Clin Sci (Lond). 1992. PMID: 1310925
-
Myocardial imaging with radiolabelled free fatty acids: a critical review.Eur Heart J. 1985 Aug;6 Suppl B:29-38. doi: 10.1093/eurheartj/6.suppl_b.29. Eur Heart J. 1985. PMID: 3910439 Review. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources